Search | Page 4 | Aplastic Anemia and MDS International Foundation


Search results

  1. Calcineurin Inhibitor-Free Interventions for Prevention of Graft-versus-Host Disease (BMT CTN 1301)

    ... undergoing myeloablative conditioning hematopoietic stem cell transplantation. ... Exclusion Criteria:  Prior autologous or allogeneic hematopoietic stem cell transplant ...

    Clinical Trial last updated 06/06/2016 - 1:36pm.

  2. Randomized Trial of Lenalidomide, Bortezomib, Dexamethasone vs High-Dose Treatment With SCT in MM Patients up to Age 65 (DFCI 10-106)

    ... and cyclophosphamide , the drugs used during stem cell collection and transplant, are also approved by the FDA. Melphalan is ... bortezomib and dexamethasone alone or when combined with autologous stem cell transplantation to see what side effects it may have and ...

    Clinical Trial last updated 05/23/2016 - 3:45pm.

  3. Intra-Osseous Co-Transplant of UCB and hMSC

    ... the patient's immune system from rejecting the donor's stem cells . The donated stem cells may replace the patient's immune cells ... (myeloid sarcoma or chloroma) Recipients of prior autologous or allogeneic transplant are eligible, as long as at least 3 months ...

    Clinical Trial last updated 05/02/2016 - 11:15am.